HTG Molecular Diagnostics, Inc.
OTC: HTGMQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John L. Lubniewski
- Employees
- 53
- Headquarters
- Tucson, United States
- IPO year
- 2015
- Market cap
- $221.0
- Website
- https://www.htgmolecular.com
Loading HTGMQ…
Loading profile data…Frequently asked questions about HTGMQ
What does HTG Molecular Diagnostics, Inc. (HTGMQ) do?
HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applications engineered to automate the processing of samples and characterize a variety of molecular targets. Among their portfolio of molecular profiling p...
Where does HTGMQ trade?
HTG Molecular Diagnostics, Inc. (HTGMQ) trades on the Other OTC.
What sector is HTGMQ in?
HTG Molecular Diagnostics, Inc. (HTGMQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of HTG Molecular Diagnostics, Inc.?
John L. Lubniewski is the chief executive officer of HTG Molecular Diagnostics, Inc. (HTGMQ).
Where is HTG Molecular Diagnostics, Inc. headquartered?
HTG Molecular Diagnostics, Inc. is headquartered in United States.
Does HTGMQ pay a dividend?
HTG Molecular Diagnostics, Inc. (HTGMQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HTGMQ go public?
HTG Molecular Diagnostics, Inc. (HTGMQ) completed its initial public offering in 2015.